Top Clinical Trials companies in Denmark by EPS (Diluted)

This ranking features the top 5 Clinical Trials companies in Denmark ranked by EPS (Diluted), averaging a EPS (Diluted) of USD 1.73, for January 15, 2025.
#
Name
EPS (Diluted)
Reported Date
Stock Price
Change
Price (30 days) Country
1
USD 9.77
Dec. 31, 2023 USD 216.88 1.28%

Denmark

2
USD -0.00
Dec. 31, 2023 USD 0.64 1.38%

Denmark

3
USD -0.13
Dec. 31, 2023 USD 0.57 1.47%

Denmark

4
USD -0.48
Dec. 31, 2023 USD 3.98 0.01%

Denmark

5
USD -0.52
Dec. 31, 2023 USD 1.93 -6.19%

Denmark

Frequently Asked Questions
  • Which Clinical Trials company in Denmark has the highest EPS (Diluted) ?

    The Clinical Trials company in Denmark with the highest EPS (Diluted) is Genmab A/S (Copenhagen Stock Exchange: GMAB.CO) at USD 9.77.

  • Which Clinical Trials company in Denmark has the lowest EPS (Diluted) ?

    The Clinical Trials company in Denmark with the lowest EPS (Diluted) is ViroGates A/S (Copenhagen Stock Exchange: VIRO.CO) at USD -0.52.